Do you want to read an article? Please log in or register.
CLINICAL PROTOCOL FOR THE USE OF BIOLOGIC THERAPY IN COPD
COPD
RECOMMENDED
Related content
RECOMMENDED
Asthma
Green Light for Response: Clinical Stratification of Response to Biologic Therapy in Severe Asthma
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Asthma Allergy
Lopez-Rodríguez R, Cañas JA, Mahíllo-Fernández I, Rial MJ
doi: 10.2147/JAA.S577215
COPD
Glucocorticoid Treatment in Severe COPD Exacerbations: Biological Rationale, Clinical Effects, and Practical Advice
Semin Respir Crit Care Med
Sartori F, Sartori G, Di Chiara C, Fantin A, Crisafulli E
doi: 10.1055/a-2693-0577
RECOMMENDED
Asthma
Clinical Remission and Its Determinants in Adult Severe Asthma Patients Receiving Biologic Therapy: A Retrospective Analysis
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Med
Ediger D, Aktepe Sezgin EN, Tülümen Öztürk R, Çoban B
doi: 10.3390/jcm15020442
RECOMMENDED
COPDPneumonia
Comparing Major COPD Triple Therapy Trials Using a Structured Multi-Criteria Decision Analysis: A Deep Dive into Patient Populations and Outcomes
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respir Med
Cazzola M, Maniscalco M, Patella V, Calzetta L, Matera MG, Rogliani P
doi: 10.1016/j.rmed.2025.108292
RECOMMENDED
COPD
TETRIS - Prospective study to observe clinical outcomes of triple therapy in COPD patients: up to 12 months interim analysis
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Rohde G, Vogelmeier CF, Beeh KM, Kardos P, Paulsson T, Watz H, Westermayer B, Mohan T, Noorduyn SG, Claussen J
doi: 10.1016/j.rmed.2025.108597
COPD
Comparison of the Risk of Pneumonia Between Fluticasone Furoate/Umeclidinium/Vilanterol and Multiple-Inhaler Triple Therapy in Patients with COPD Using Health Insurance Claims Data: Final Analysis of Post-Marketing Database Surveillance in Japan
J Clin Med
Akiyama S, Oda K, Mizohata H, Sasakura N, Hashimoto K, Maruoka H
doi: 10.3390/jcm14134697
COPD
Step up to triple therapy versus switch to dual bronchodilator therapy in patients with COPD on an inhaled corticosteroid/long-acting β(2)-agonist: post-hoc analyses of KRONOS
Respir Res
Singh D, Bafadhel M, Arya N, Marshall J, Parikh H, Kisielewicz D, Movitz C, Bowen K, Patel M
doi: 10.1186/s12931-025-03234-5
COMMENTED
COPD
Efficacy and safety of ensifentrine in treatment of COPD: a systematic review and meta-analysis of clinical trials
★ 3
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Ther Adv Respir Dis
Hammadeh BM, Younis OM, Alsufi MI, Idrees M, Hussein AM, Aldalati AY, Qtaishat FA, Qatawneh B, Bugazia A, Hamed RA
doi: 10.1177/17534666251347775
COMMENTED
Asthma
Clinical Remission in Severe Asthma: A Comparative Analysis of Patients with and Without Biologics from the Swiss Severe Asthma Registry
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended and commented by
Dr Marcus Hesse, Faculty Member
Biomedicines
Jaun F, Boesing M, Lüthi-Corridori G, Bridevaux PO, Charbonnier F, Clarenbach CF, Fellrath JM, Gianella P, Jochmann A, Kern L, Pavlov N, Latshang TD, Von Garnier C, Leuppi JD
doi: 10.3390/biomedicines13123074